Finance

Lists
Q2 2026 earnings • released • Revenue beat +7.84%
See results
MOC:WSE
Molecure SA
PLN 7.22
+1.98%
(+0.14) 1D
Oct 5, 11:37:18 AM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for MOC...
Open
PLN 7.28
High
PLN 7.56
Low
PLN 7.22
Mkt. cap
178.51M
Avg. vol.
72.59K
Volume
17.92K
52-wk high
PLN 9.04
52-wk low
PLN 4.98
EPS
-PLN 0.71
Shares outstanding
24.72M
No. of employees
45
Open
PLN 7.28
High
PLN 7.56
Low
PLN 7.22
Mkt. cap
178.51M
Avg. vol.
72.59K
Volume
17.92K
52-wk high
PLN 9.04
52-wk low
PLN 4.98
EPS
-PLN 0.71
Shares outstanding
24.72M
No. of employees
45
News stories
From web sources and news partners
About Molecure SA
CEOMarcin Jan Szumowski
Employees45
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitemolecure.com
Last report
Sep 30, 2026
Fiscal period
Q2 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
1.40M / 1.30M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.91M
214.80K
2.95M
118.79K
Cost of goods sold
320.70K
362.37K
21.71M
-
Cost of revenue
320.70K
362.37K
21.71M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.51M
4.48M
-14.43M
-
Operating expense
6.34M
5.30M
-16.96M
-
Total operating expenses
6.66M
5.66M
4.75M
-
Operating income
-3.76M
-5.45M
-1.81M
-
Other non operating income
78.13K
-
801.03K
-
EBT including unusual items
-3.51M
-5.27M
-1.73M
-
EBT excluding unusual items
-3.51M
-5.27M
-1.73M
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
16.14K
75.87K
-191.15K
-
Net income
-3.51M
-5.27M
-1.73M
-
Net profit margin
-120.74%
-2,451.83%
-58.66%
-
Earnings per share
-
-
-
-
Interest and investment income
200.50K
212.00K
40.09K
-
Interest expense
-14.54K
-30.99K
-811.85K
-
Net interest expenses
185.96K
181.01K
-771.76K
-
Depreciation and amortization charges
811.92K
745.28K
-2.33M
-
EBITDA
-3.52M
-5.22M
-1.58M
-
Gain or loss from assets sale
-18.95K
-39.50K
58.44K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps